VCIM
KURA icon

Velan Capital Investment Management’s Kura Oncology KURA Stock Holding History

Velan Capital Investment Management’s Portfolio KURA Stock Details KURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-150,000
Closed -$1.31M – 54
2024
Q4 		$1.31M Buy
+150,000
New +$2.16M 1.13% 16

Other funds holding KURA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Velan Capital Investment Management's KURA Position: Q1 2025 in Review

Velan Capital Investment Management sold out of Kura Oncology (KURA) in Q1 2025, closing a stake of 150,000 shares — an estimated $1.31M sold.

Velan Capital Investment Management first reported a position in KURA in Q4 2024 and held it in 1 quarter. The position peaked at $1.31M in Q4 2024. 183 funds tracked by Wall St. Rank hold KURA as of Q1 2025.

  • Velan Capital Investment Management reported no remaining Kura Oncology position as of Q1 2025 after selling out during the quarter.
  • Velan Capital Investment Management sold 150,000 Kura Oncology shares in Q1 2025, an estimated $1.31M.
  • Velan Capital Investment Management first reported a position in Kura Oncology in Q4 2024 and held it in 1 quarter.
  • Velan Capital Investment Management's Kura Oncology position peaked at $1.31M in Q4 2024.
  • 183 funds tracked by Wall St. Rank held Kura Oncology as of Q1 2025.

Based on Velan Capital Investment Management's 13F filing for Q1 2025, filed 15 May 2025.